MedPath

Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy

Not Applicable
Conditions
Kidney Neoplasms
Renal Cell Carcinoma
Registration Number
NCT01892059
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

The purpose of this study is to compare the efficacy and safety of the segmental artery clamping and main renal artery clamping during laparoscopic partial nephrectomy

Detailed Description

Renal tumor patients,for whom laparoscopic partial nephrectomy is suitable, will be randomly divided into two groups,segmental artery clamping group and main artery clamping group. All procedures were performed by the same laparoscopic surgeon. Blood loss, operation time, warm ischemia time, complications and affected renal function before and after operation will be recorded and compared. The safety and efficiency of laparoscopic partial nephrectomy with segmental renal artery clamping will be evaluated in comparison with the conventional main renal artery clamping technique.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 20<age<70yr
  • Stage T1a
  • Patients volunteered for this study and provided written informed consent
Exclusion Criteria
  • Bilateral renal tumor
  • tumor of solitary kidney
  • glomerulonephritis
  • renal insufficiency
  • GFR of invalid kidney less than 30ml/min
  • presence of suspect metastasis
  • serious systematic disease: severe coagulation disorders
  • important organ insufficiency and severe psychological disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Glomerular Filtration Rate3 months postoperative
Secondary Outcome Measures
NameTimeMethod
warm ischemia timeduring surgery

Trial Locations

Locations (1)

Department of Urology, First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

Department of Urology, First Affiliated Hospital of Nanjing Medical University
🇨🇳Nanjing, Jiangsu, China
Pu Li
Contact
+25 68136875
lee_lipu@163.com
Changjun Yin
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.